Drug Pricing - MM+M - Medical Marketing and Media

Drug Pricing

All articles by Drug Pricing

Eli Lilly, Johnson & Johnson take initiative, get in front of PhRMA guidelines
Eli Lilly, Johnson & Johnson take initiative, get in front of PhRMA guidelines
Alison Kanski
April 4, 2019
5:00 am

Eli Lilly and Johnson & Johnson take the lead on PhRMA’s new guidelines for DTC ads.

First TV drug ad featuring list price debuts today
First TV drug ad featuring list price debuts today
Alison Kanski
March 29, 2019
12:15 pm

The spot for Johnson & Johnson blood thinner Xarelto comes ahead of a rule, proposed by the Trump administration in October, which would require drugmakers to disclose list prices in TV ads. The rule faces opposition from trade group PhRMA.

Expect legislative baby steps, not big leaps on drug prices
Expect legislative baby steps, not big leaps on drug prices
Alison Kanski
March 4, 2019
5:00 am

Even though both parties agree on lowering drug prices, experts predict changes will be incremental.

4 takeaways from Tuesday’s Senate drug pricing hearing
4 takeaways from Tuesday’s Senate drug pricing hearing
Alison Kanski
February 26, 2019
5:07 pm

Seven pharma executives were grilled on drug prices on Capitol Hill on Tuesday.

Live blog: Pharma execs on the Hill
Live blog: Pharma execs on the Hill
Alison Kanski
February 26, 2019
11:13 am

The latest from the Senate Finance Committee’s grilling of pharma executives on Capitol Hill.

Clarity in DTC TV ad drug pricing
Clarity in DTC TV ad drug pricing
Belle Frank
February 8, 2019
6:00 am

Belle Frank is chief strategy officer, global health practice at VMLY&R.

Johnson & Johnson to put list prices in TV drug ads
Johnson & Johnson to put list prices in TV drug ads
Alison Kanski
February 7, 2019
4:29 pm

The drugmaker will add list prices to ads for Xarelto by the end of March.

Was President Trump’s plan to reduce drug prices DOA?
Was President Trump’s plan to reduce drug prices DOA?
Sander A. Flaum
February 7, 2019
6:00 am

President Trump’s blueprint to lower drug prices hasn’t made it out of the brainstorm phase.

Cassidy, Warner draft bill to promote value-based payment models
Cassidy, Warner draft bill to promote value-based payment models
Alison Kanski
January 31, 2019
10:48 am

Senators Bill Cassidy and Mark Warner are taking feedback from the public before introducing the bill.

The next five years of pharma: Pricing, biosimilars, and specialty medicines
The next five years of pharma: Pricing, biosimilars, and specialty medicines
Alison Kanski
January 29, 2019
10:11 am

A report from the IQVIA Institute for Human Data Science identified areas to watch through 2023.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners